AI Score
Our AI model analyzes fundamental, technical, and statistical indicators
to predict the probability of a bullish trend over the next three months.
We regularly update and refine our models to deliver the most reliable forecasts
for you.
Bullish Probability | Sentiment | Score |
---|---|---|
+80% | Strong Buy | 10 |
+75% | Buy | 9 |
+70% | Buy | 8 |
+60% | Buy | 7 |
+50% | Hold | 6 |
+45% | Hold | 5 |
+40% | Hold | 4 |
+35% | Sell | 3 |
+30% | Sell | 2 |
+20% | Strong Sell | 1 |
Bid | 16.8 |
Market Cap | 6.07B |
Revenue (ttm) | - |
Net Income (ttm) | - |
EPS (ttm) | -1.02 |
PE Ratio (ttm) | -16.89 |
Forward PE | n/a |
Analyst | Hold |
Ask | 17.27 |
Volume | 551,456 |
Avg. Volume (20D) | 507,734 |
Open | 17.37 |
Previous Close | 17.37 |
Day's Range | 16.75 - 17.40 |
52-Week Range | 13.16 - 21.69 |
Beta | undefined |
About BLCO
Bausch + Lomb Corporation operates as an eye health company worldwide. It operates through three segments: Vision Care/Consumer Health Care, Ophthalmic Pharmaceuticals, and Surgical. The Vision Care/Consumer Health Care segment provides contact lens that covers the spectrum of wearing modalities, including daily disposable and frequently replaced contact lenses; and contact lens care products, over-the-counter eye drops, eye vitamins, and mineral...
Analyst Forecast
According to 12 analyst ratings, the average rating for BLCO stock is "Hold." The 12-month stock price forecast is $19, which is an increase of 10.30% from the latest price.
Next Earnings Release
Analysts project revenue of $1.26B, reflecting a 7.42% YoY growth and earnings per share of 0.24, making a 0.00% YoY.
2 months ago · seekingalpha.com
Bausch + Lomb Corporation (BLCO) Q3 2024 Earnings Call TranscriptBausch + Lomb Corporation (NYSE:BLCO ) Q3 2024 Results Conference Call October 30, 2024 8:00 AM ET Company Participants George Gadkowski - Vice President of Investor Relations and Business Insights Br...